Long-term efficacy and safety of etrasimod for ulcerative colitis: results from the open-label extension of the OASIS study

Severine Vermeire  ¹     Julian Panés  ²     Michael Chiorean  ³     Laurent Peyrin-Biroulet  ⁴     Jinkun Zhang  ⁵     Bruce E. Sands  ⁶     Krisztina Lazin     Chris Cabell     Snehal U. Naik     Preston Klassen     William Sandborn    
¹ University Hospitals Leuven,Leuven,Belgium
² Hospital Clínic de Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
³ Virginia Mason Medical Center,Seattle,United States
⁴ Lorraine University, INSERM U 954,Vandoeuvre-lès-Nancy,France
⁵ Arena Pharmaceuticals,San Diego,United States
⁶ Icahn School of Medicine at Mount Sinai,New York,United States;;

Session
IBD I (Posters)

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019